Decoy Therapeutics, Inc. has announced a $21 million Private Placement Financing, with $3.5 million in upfront proceeds from a healthcare-focused investor, aimed at advancing clinical trials.
Amount Raised
$3.5 Million
Round Type
Post-IPO Equity
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Decoy Therapeutics, Inc. has entered into a securities purchase agreement for a private investment in public equity financing, expected to provide approximately $3.5 million in gross proceeds. The company plans to use the net proceeds to advance its lead asset into clinical trials. The financing includes additional potential gross proceeds based on milestones for Series A, B, and C warrants
Quick answer
Decoy Therapeutics raised $3.5 Million in a Post-IPO Equity round, dated June 29, 2026. Investors: Single Healthcare Focused Institutional Investor. Decoy Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Decoy Therapeutics raise?
- Decoy Therapeutics raised $3.5 Million in a Post-IPO Equity round on June 29, 2026.
- Who invested in Decoy Therapeutics?
- Single Healthcare Focused Institutional Investor is named as investors in this round.
- What does Decoy Therapeutics do?
- Decoy Therapeutics, based in Cambridge, Massachusetts, is a pharmaceutical company focused on leveraging artificial intelligence to develop treatments for respiratory diseases.
- Where is Decoy Therapeutics based and how big is it?
- Decoy Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 2 employees.
- Who are the decision-makers at Decoy Therapeutics?
- Fundz holds 1 contact at Decoy Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Decoy Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Vaderis Therapeutics raised $152M (Series B) on August 11, 2026.
- Os Therapies raised $5M on August 10, 2026.
- Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
- Acasti raised $10M on August 4, 2026.
- Ratio Therapeutics raised $70M (Series C) on July 31, 2026.
- Kaveri Therapeutics raised $1.6M (Seed) on July 21, 2026.
Who to call at Decoy Therapeutics, and when
A new round usually means Decoy Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Decoy Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Decoy Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Decoy Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Decoy Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Decoy Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.